Erytech Pharma SA - Delisted Stock
Erytech Pharma SA is currently unavailable and cannot be used in your analysis. The information on this page reflects the last day Erytech Pharma was actively traded.
Valuation
Check how we calculate scores
Erytech Pharma SA Risk Profiles
Investors will always prefer to have the highest possible return on investment while minimizing volatility. Erytech Pharma market risk premium is the additional return an investor will receive from holding Erytech Pharma long position in a well-diversified portfolio.
Mean Deviation | 4.72 | |||
Standard Deviation | 7.09 | |||
Variance | 50.23 | |||
Risk Adjusted Performance | 0.0013 |
View Erytech Pharma Related Equities
Risk & Return | Correlation |
Erytech Pharma Corporate Management
Gil BVBA | CEO Director | Profile | |
Iman MD | Chief Officer | Profile | |
Philip Lorenzi | Consultant Board | Profile | |
AnneCcile Fumey | HR Director | Profile | |
Brian Schwab | Chief Counsel | Profile | |
Naomi Eichenbaum | Director Relations | Profile |
Still Interested in Erytech Pharma SA?
Investing in delisted delisted stocks can be risky, as the stock is no longer traded on a public exchange and can therefore be difficult to sell. Delisting typically occurs when a company has failed to meet exchange requirements or has been acquired. Before investing, it's important to thoroughly research the company, including its financial health and prospects for the future, as well as the reasons for its delisting. Additionally, it may be difficult to find accurate and up-to-date information on the company and its stock.
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Other Consideration for investing in Erytech Stock
If you are still planning to invest in Erytech Pharma SA check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Erytech Pharma's history and understand the potential risks before investing.
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios |